Clear.bio
Reverse type 2 diabetes with nutrition
Amsterdam, Netherlands · Founded 2019 · $3.0M raised
- Headquarters
- Amsterdam
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2C
- Website
- clear.bio
- Total Funding
- $3.0M
- Last Round
- $1.9M SeedSep 2025
- Rounds
- 2
About
Clear.bio is an Amsterdam-based healthtech company that helps people with type 2 diabetes reverse their condition through personalized, data-driven nutrition. Using a continuous glucose sensor and a smart app, the platform shows users in real time how their body responds to food and provides coaching from dietitians. Founded in 2019, Clear.bio is an officially licensed care provider in the Netherlands with thousands of patients treated.
Summary
Clear.bio is a Healthcare company based in Amsterdam, Netherlands, founded in 2019. It has raised $3.0M in total across 2 rounds, most recently a $1.9M Seed round in Sep 2025. Investors include Google Accelerator and Antler.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Hyland provides content services and intelligent automation solutions for enterprises.
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...